Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B
Clinical trial NCT04489537 · TERMINATED
Trial details
- NCT number
- NCT04489537
- Sponsor
- Catalyst Biosciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2021-11-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.